Global Vaccines Market By Product Type (Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, and Toxoid vaccines), Viral vector vaccines, mRNA vaccines, Live Attenuated, and Inactivated), By Route of Administration (Oral, Parenteral, and Nasal), By Application (Viral Diseases (Hepatitis, Influenza, Rotavirus, and Others), Bacterial Vaccines (Meningococcal Diseases, Pneumococcal diseases, DPT, and Others), Cancer Vaccines, and Allergy Vaccines), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Vaccines Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Vaccines Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Vaccines Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 3.3. Global Vaccines Market Attractiveness Analysis, By Product Type
    • 3.3.1. MRNA Vaccines
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Subunit Vaccines
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
    • 3.3.3. Viral Vector Vaccines
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
    • 3.3.4. Live Attenuated
      • 3.3.4.1. Insights
      • 3.3.4.2. Key Takeaways
    • 3.3.5. Inactivated
      • 3.3.5.1. Insights
      • 3.3.5.2. Key Takeaways
  • 3.4. Global Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 3.5. Global Vaccines Market Attractiveness Analysis, By Route of Administration
    • 3.5.1. Parenteral
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Oral
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Nasal
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
  • 3.6. Global Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 3.7. Global Vaccines Market Attractiveness Analysis, By Application
    • 3.7.1. Viral Diseases
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Bacterial Vaccines
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Cancer Vaccines
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
    • 3.7.4. Allergy Vaccines
      • 3.7.4.1. Insights
      • 3.7.4.2. Key Takeaways
  • 3.8. Global Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 3.9. Global Vaccines Market Attractiveness Analysis, By Distribution Channel
    • 3.9.1. Government Suppliers
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Hospital & Retail Pharmacies
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
    • 3.9.3. Others
      • 3.9.3.1. Insights
      • 3.9.3.2. Key Takeaways
• 4. Global Vaccines Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Vaccines Market Attractiveness Analysis, By Region
• 5. North America Vaccines Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 5.3. North America Vaccines Market Attractiveness Analysis, By Product Type
  • 5.4. North America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 5.5. North America Vaccines Market Attractiveness Analysis, By Route of Administration
  • 5.6. North America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 5.7. North America Vaccines Market Attractiveness Analysis, By Application
  • 5.8. North America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 5.9. North America Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 5.10. North America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.11. North America Vaccines Market Attractiveness Analysis, By Country
    • 5.11.1. The US
    • 5.11.2. Canada
• 6. Europe Vaccines Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 6.3. Europe Vaccines Market Attractiveness Analysis, By Product Type
  • 6.4. Europe Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 6.5. Europe Vaccines Market Attractiveness Analysis, By Route of Administration
  • 6.6. Europe Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 6.7. Europe Vaccines Market Attractiveness Analysis, By Application
  • 6.8. Europe Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 6.9. Europe Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 6.10. Europe Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.11. Europe Vaccines Market Attractiveness Analysis, By Country
    • 6.11.1. Germany
    • 6.11.2. The UK
    • 6.11.3. France
    • 6.11.4. Spain
    • 6.11.5. Italy
    • 6.11.6. Russia
    • 6.11.7. Netherland
    • 6.11.8. Rest of Europe
• 7. Asia Pacific Vaccines Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 7.3. Asia Pacific Vaccines Market Attractiveness Analysis, By Product Type
  • 7.4. Asia Pacific Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 7.5. Asia Pacific Vaccines Market Attractiveness Analysis, By Route of Administration
  • 7.6. Asia Pacific Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 7.7. Asia Pacific Vaccines Market Attractiveness Analysis, By Application
  • 7.8. Asia Pacific Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 7.9. Asia Pacific Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 7.10. Asia Pacific Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.11. Asia Pacific Vaccines Market Attractiveness Analysis, By Country
    • 7.11.1. China
    • 7.11.2. Japan
    • 7.11.3. South Korea
    • 7.11.4. India
    • 7.11.5. Australia
    • 7.11.6. New Zealand
    • 7.11.7. Singapore
    • 7.11.8. Thailand
    • 7.11.9. Vietnam
    • 7.11.10. Rest of Asia Pacific
• 8. Latin America Vaccines Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 8.3. Latin America Vaccines Market Attractiveness Analysis, By Product Type
  • 8.4. Latin America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 8.5. Latin America Vaccines Market Attractiveness Analysis, By Route of Administration
  • 8.6. Latin America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 8.7. Latin America Vaccines Market Attractiveness Analysis, By Application
  • 8.8. Latin America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 8.9. Latin America Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 8.10. Latin America Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.11. Latin America Vaccines Market Attractiveness Analysis, By Country
    • 8.11.1. Brazil
    • 8.11.2. Mexico
    • 8.11.3. Rest of Latin America
• 9. Middle East & Africa Vaccines Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 9.3. Middle East & Africa Vaccines Market Attractiveness Analysis, By Product Type
  • 9.4. Middle East & Africa Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 9.5. Middle East & Africa Vaccines Market Attractiveness Analysis, By Route of Administration
  • 9.6. Middle East & Africa Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 9.7. Middle East & Africa Vaccines Market Attractiveness Analysis, By Application
  • 9.8. Middle East & Africa Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 9.9. Middle East & Africa Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 9.10. Middle East & Africa Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.11. Middle East & Africa Vaccines Market Attractiveness Analysis, By Country
    • 9.11.1. South Africa
    • 9.11.2. Saudi Arabia
    • 9.11.3. UAE
    • 9.11.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
  • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Novavax
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Dr. Reddy’s Laboratories
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Sanofi
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. GSK Plc
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Pfizer
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. Moderna
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
    • 10.7.6.7. Geographic Footprint
      • 10.7.7. Sinovac
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. AstraZeneca
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 2. Global Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 3. Global Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 4. Global Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 5. Global Vaccines Market Value (US$ Mn), By Region, 2020-2034
• Table 6. North America Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 7. North America Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 8. North America Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 9. North America Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 10. North America Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 11. The US Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 12. The US Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 13. The US Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 14. The US Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 15. Canada Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 16. Canada Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 17. Canada Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 18. Canada Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 19. Europe Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 20. Europe Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 21. Europe Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 22. Europe Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 23. Europe Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 24. Germany Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 25. Germany Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 26. Germany Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 27. Germany Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 28. The UK Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 29. The UK Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 30. The UK Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 31. The UK Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 32. France Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 33. France Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 34. France Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 35. France Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 36. Spain Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 37. Spain Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 38. Spain Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 39. Spain Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 40. Italy Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 41. Italy Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 42. Italy Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 43. Italy Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 44. Russia Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 45. Russia Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 46. Russia Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 47. Russia Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 48. Netherland Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 49. Netherland Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 50. Netherland Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 51. Netherland Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 52. Rest of Europe Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 53. Rest of Europe Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 54. Rest of Europe Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 55. Rest of Europe Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 56. Asia Pacific Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 57. Asia Pacific Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 58. Asia Pacific Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 59. Asia Pacific Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 60. Asia Pacific Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 61. China Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 62. China Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 63. China Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 64. China Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 65. India Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 66. India Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 67. India Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 68. India Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 69. Japan Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 70. Japan Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 71. Japan Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 72. Japan Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 73. South Korea Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 74. South Korea Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 75. South Korea Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 76. South Korea Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 77. Australia Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 78. Australia Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 79. Australia Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 80. Australia Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 81. New Zealand Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 82. New Zealand Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 83. New Zealand Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 84. New Zealand Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 85. Singapore Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 86. Singapore Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 87. Singapore Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 88. Singapore Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 89. Thailand Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 90. Thailand Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 91. Thailand Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 92. Thailand Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 93. Vietnam Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 94. Vietnam Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 95. Vietnam Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 96. Vietnam Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 97. Rest of Asia Pacific Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 98. Rest of Asia Pacific Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 99. Rest of Asia Pacific Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 100. Rest of Asia Pacific Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 101. Latin America Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 102. Latin America Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 103. Latin America Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 104. Latin America Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 105. Latin America Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 106. Brazil Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 107. Brazil Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 108. Brazil Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 109. Brazil Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 110. Mexico Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 111. Mexico Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 112. Mexico Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 113. Mexico Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 114. Rest of Latin America Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 115. Rest of Latin America Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 116. Rest of Latin America Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 117. Rest of Latin America Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 118. Middle East & Africa Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 119. Middle East & Africa Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 120. Middle East & Africa Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 121. Middle East & Africa Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 122. Middle East & Africa Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 123. South Africa Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 124. South Africa Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 125. South Africa Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 126. South Africa Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 127. Saudi Arabia Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 128. Saudi Arabia Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 129. Saudi Arabia Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 130. Saudi Arabia Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 131. UAE Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 132. UAE Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 133. UAE Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 134. UAE Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 135. Rest of Middle East & Africa Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 136. Rest of Middle East & Africa Vaccines Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 137. Rest of Middle East & Africa Vaccines Market Value (US$ Mn), By Application, 2020-2034
• Table 138. Rest of Middle East & Africa Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034

List of Figures

• Figure 1. Global Vaccines Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Vaccines Market
• Figure 5. Global Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 6. Global Vaccines Market Attractiveness Analysis, By Product Type
• Figure 7. Global Vaccines Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 8. Global Vaccines Market Attractiveness Analysis, By Route of Administration
• Figure 9. Global Vaccines Market Analysis, By Application, 2020, 2024 and 2034
• Figure 10. Global Vaccines Market Attractiveness Analysis, By Application
• Figure 11. Global Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 12. Global Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 13. Global Vaccines Market Analysis, By Region, 2020, 2024 and 2034
• Figure 14. Global Vaccines Market Attractiveness Analysis, By Region
• Figure 15. North America Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 16. North America Vaccines Market Attractiveness Analysis, By Product Type
• Figure 17. North America Vaccines Market (US$ Mn), by MRNA Vaccines, 2020-2034
• Figure 18. North America Vaccines Market (US$ Mn), by Subunit Vaccines, 2020-2034
• Figure 19. North America Vaccines Market (US$ Mn), by Viral Vector Vaccines, 2020-2034
• Figure 20. North America Vaccines Market (US$ Mn), by Live Attenuated, 2020-2034
• Figure 21. North America Vaccines Market (US$ Mn), by Inactivated, 2020-2034
• Figure 22. North America Vaccines Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 23. North America Vaccines Market Attractiveness Analysis, By Route of Administration
• Figure 24. North America Vaccines Market (US$ Mn), by Parenteral, 2020-2034
• Figure 25. North America Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 26. North America Vaccines Market (US$ Mn), by Nasal, 2020-2034
• Figure 27. North America Vaccines Market Analysis, By Application, 2020, 2024 and 2034
• Figure 28. North America Vaccines Market Attractiveness Analysis, By Application
• Figure 29. North America Vaccines Market (US$ Mn), by Viral Diseases, 2020-2034
• Figure 30. North America Vaccines Market (US$ Mn), by Bacterial Vaccines, 2020-2034
• Figure 31. North America Vaccines Market (US$ Mn), by Cancer Vaccines, 2020-2034
• Figure 32. North America Vaccines Market (US$ Mn), by Allergy Vaccines, 2020-2034
• Figure 33. North America Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 34. North America Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 35. North America Vaccines Market (US$ Mn), by Government Suppliers, 2020-2034
• Figure 36. North America Vaccines Market (US$ Mn), by Hospital & Retail Pharmacies, 2020-2034
• Figure 37. North America Vaccines Market (US$ Mn), by Others, 2020-2034
• Figure 38. North America Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 39. North America Vaccines Market Attractiveness Analysis, By Country
• Figure 40. Europe Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 41. Europe Vaccines Market Attractiveness Analysis, By Product Type
• Figure 42. Europe Vaccines Market (US$ Mn), by MRNA Vaccines, 2020-2034
• Figure 43. Europe Vaccines Market (US$ Mn), by Subunit Vaccines, 2020-2034
• Figure 44. Europe Vaccines Market (US$ Mn), by Viral Vector Vaccines, 2020-2034
• Figure 45. Europe Vaccines Market (US$ Mn), by Live Attenuated, 2020-2034
• Figure 46. Europe Vaccines Market (US$ Mn), by Inactivated, 2020-2034
• Figure 47. Europe Vaccines Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 48. Europe Vaccines Market Attractiveness Analysis, By Route of Administration
• Figure 49. Europe Vaccines Market (US$ Mn), by Parenteral, 2020-2034
• Figure 50. Europe Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 51. Europe Vaccines Market (US$ Mn), by Nasal, 2020-2034
• Figure 52. Europe Vaccines Market Analysis, By Application, 2020, 2024 and 2034
• Figure 53. Europe Vaccines Market Attractiveness Analysis, By Application
• Figure 54. Europe Vaccines Market (US$ Mn), by Viral Diseases, 2020-2034
• Figure 55. Europe Vaccines Market (US$ Mn), by Bacterial Vaccines, 2020-2034
• Figure 56. Europe Vaccines Market (US$ Mn), by Cancer Vaccines, 2020-2034
• Figure 57. Europe Vaccines Market (US$ Mn), by Allergy Vaccines, 2020-2034
• Figure 58. Europe Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 59. Europe Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 60. Europe Vaccines Market (US$ Mn), by Government Suppliers, 2020-2034
• Figure 61. Europe Vaccines Market (US$ Mn), by Hospital & Retail Pharmacies, 2020-2034
• Figure 62. Europe Vaccines Market (US$ Mn), by Others, 2020-2034
• Figure 63. Europe Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 64. Europe Vaccines Market Attractiveness Analysis, By Country
• Figure 65. Asia Pacific Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 66. Asia Pacific Vaccines Market Attractiveness Analysis, By Product Type
• Figure 67. Asia Pacific Vaccines Market (US$ Mn), by MRNA Vaccines, 2020-2034
• Figure 68. Asia Pacific Vaccines Market (US$ Mn), by Subunit Vaccines, 2020-2034
• Figure 69. Asia Pacific Vaccines Market (US$ Mn), by Viral Vector Vaccines, 2020-2034
• Figure 70. Asia Pacific Vaccines Market (US$ Mn), by Live Attenuated, 2020-2034
• Figure 71. Asia Pacific Vaccines Market (US$ Mn), by Inactivated, 2020-2034
• Figure 72. Asia Pacific Vaccines Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 73. Asia Pacific Vaccines Market Attractiveness Analysis, By Route of Administration
• Figure 74. Asia Pacific Vaccines Market (US$ Mn), by Parenteral, 2020-2034
• Figure 75. Asia Pacific Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 76. Asia Pacific Vaccines Market (US$ Mn), by Nasal, 2020-2034
• Figure 77. Asia Pacific Vaccines Market Analysis, By Application, 2020, 2024 and 2034
• Figure 78. Asia Pacific Vaccines Market Attractiveness Analysis, By Application
• Figure 79. Asia Pacific Vaccines Market (US$ Mn), by Viral Diseases, 2020-2034
• Figure 80. Asia Pacific Vaccines Market (US$ Mn), by Bacterial Vaccines, 2020-2034
• Figure 81. Asia Pacific Vaccines Market (US$ Mn), by Cancer Vaccines, 2020-2034
• Figure 82. Asia Pacific Vaccines Market (US$ Mn), by Allergy Vaccines, 2020-2034
• Figure 83. Asia Pacific Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 84. Asia Pacific Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 85. Asia Pacific Vaccines Market (US$ Mn), by Government Suppliers, 2020-2034
• Figure 86. Asia Pacific Vaccines Market (US$ Mn), by Hospital & Retail Pharmacies, 2020-2034
• Figure 87. Asia Pacific Vaccines Market (US$ Mn), by Others, 2020-2034
• Figure 88. Asia Pacific Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 89. Asia Pacific Vaccines Market Attractiveness Analysis, By Country
• Figure 90. Latin America Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 91. Latin America Vaccines Market Attractiveness Analysis, By Product Type
• Figure 92. Latin America Vaccines Market (US$ Mn), by MRNA Vaccines, 2020-2034
• Figure 93. Latin America Vaccines Market (US$ Mn), by Subunit Vaccines, 2020-2034
• Figure 94. Latin America Vaccines Market (US$ Mn), by Viral Vector Vaccines, 2020-2034
• Figure 95. Latin America Vaccines Market (US$ Mn), by Live Attenuated, 2020-2034
• Figure 96. Latin America Vaccines Market (US$ Mn), by Inactivated, 2020-2034
• Figure 97. Latin America Vaccines Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 98. Latin America Vaccines Market Attractiveness Analysis, By Route of Administration
• Figure 99. Latin America Vaccines Market (US$ Mn), by Parenteral, 2020-2034
• Figure 100. Latin America Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 101. Latin America Vaccines Market (US$ Mn), by Nasal, 2020-2034
• Figure 102. Latin America Vaccines Market Analysis, By Application, 2020, 2024 and 2034
• Figure 103. Latin America Vaccines Market Attractiveness Analysis, By Application
• Figure 104. Latin America Vaccines Market (US$ Mn), by Viral Diseases, 2020-2034
• Figure 105. Latin America Vaccines Market (US$ Mn), by Bacterial Vaccines, 2020-2034
• Figure 106. Latin America Vaccines Market (US$ Mn), by Cancer Vaccines, 2020-2034
• Figure 107. Latin America Vaccines Market (US$ Mn), by Allergy Vaccines, 2020-2034
• Figure 108. Latin America Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 109. Latin America Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 110. Latin America Vaccines Market (US$ Mn), by Government Suppliers, 2020-2034
• Figure 111. Latin America Vaccines Market (US$ Mn), by Hospital & Retail Pharmacies, 2020-2034
• Figure 112. Latin America Vaccines Market (US$ Mn), by Others, 2020-2034
• Figure 113. Latin America Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 114. Latin America Vaccines Market Attractiveness Analysis, By Country
• Figure 115. Middle East & Africa Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 116. Middle East & Africa Vaccines Market Attractiveness Analysis, By Product Type
• Figure 117. Middle East & Africa Vaccines Market (US$ Mn), by MRNA Vaccines, 2020-2034
• Figure 118. Middle East & Africa Vaccines Market (US$ Mn), by Subunit Vaccines, 2020-2034
• Figure 119. Middle East & Africa Vaccines Market (US$ Mn), by Viral Vector Vaccines, 2020-2034
• Figure 120. Middle East & Africa Vaccines Market (US$ Mn), by Live Attenuated, 2020-2034
• Figure 121. Middle East & Africa Vaccines Market (US$ Mn), by Inactivated, 2020-2034
• Figure 122. Middle East & Africa Vaccines Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 123. Middle East & Africa Vaccines Market Attractiveness Analysis, By Route of Administration
• Figure 124. Middle East & Africa Vaccines Market (US$ Mn), by Parenteral, 2020-2034
• Figure 125. Middle East & Africa Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 126. Middle East & Africa Vaccines Market (US$ Mn), by Nasal, 2020-2034
• Figure 127. Middle East & Africa Vaccines Market Analysis, By Application, 2020, 2024 and 2034
• Figure 128. Middle East & Africa Vaccines Market Attractiveness Analysis, By Application
• Figure 129. Middle East & Africa Vaccines Market (US$ Mn), by Viral Diseases, 2020-2034
• Figure 130. Middle East & Africa Vaccines Market (US$ Mn), by Bacterial Vaccines, 2020-2034
• Figure 131. Middle East & Africa Vaccines Market (US$ Mn), by Cancer Vaccines, 2020-2034
• Figure 132. Middle East & Africa Vaccines Market (US$ Mn), by Allergy Vaccines, 2020-2034
• Figure 133. Middle East & Africa Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 134. Middle East & Africa Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 135. Middle East & Africa Vaccines Market (US$ Mn), by Government Suppliers, 2020-2034
• Figure 136. Middle East & Africa Vaccines Market (US$ Mn), by Hospital & Retail Pharmacies, 2020-2034
• Figure 137. Middle East & Africa Vaccines Market (US$ Mn), by Others, 2020-2034
• Figure 138. Middle East & Africa Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 139. Middle East & Africa Vaccines Market Attractiveness Analysis, By Country